TraceLink, Catalent announce partnership to improve production visibility for customers

TraceLink, Inc., the provider of the World's 1st Industry-Wide Supply Collaboration Network, and Catalent Pharma Solutions, Inc., a leading provider of innovative drug development and delivery solutions for pharmaceutical, biotechnology and consumer healthcare companies, today announced a partnership that will improve production visibility for Catalent customers across their entire manufacturing and packaging product lifecycle.

"This collaboration will add to the already close relationships and excellent communication Catalent shares with its customers," said Roy Satchell, Catalent's Senior Vice President, Information Technology, and Chief Information Officer.  "Our customers need strategic partners that can operate seamlessly with them in the execution of supply chain solutions. This collaboration provides that and more -- enhancing visibility, improving supply network predictability, and facilitating the incorporation of strategic solutions as part of global supply planning."

TraceLink and Catalent designed the initial solution based on customer requirements for increased information and integration. Catalent will work closely with customers to drive continuous improvement of both the service and the value generated by the capabilities.

"Our integrate-once, inter-operate with everyone approach uniquely enables Catalent and its customers to seamlessly share data and execution in a single manner," said Shabbir Dahod, President and CEO of TraceLink. "Catalent's industry leadership and passion for the customer makes them an ideal partner."

Catalent plans to continuously evolve the collaboration program based on customer feedback of data sharing and business process collaboration needs. The program will be progressively launched throughout its network starting in Q3 2010.

SOURCE TraceLink, Inc.

Posted in:

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New enzyme family enables targeted cuts in single-stranded DNA